AGP: Notice of transactions of share purchase rights of Directors, PDMR and connected person

- Name of issuer: Agimexpharm Pharmaceutical Joint Stock Company
- Stock code: AGP
- Securities type: Common stock
- Name of person discharging managerial responsibility (PDMR)/Director: Pham Thi Bich Thuy
- Position in the listed company: Chair of the Board-of-Director-cum-Deputy Managing Director
- Number of shares held by person discharging managerial responsibility (PDMR)/Director: 445,779 shares (1.67%)
- Number of rights to purchase shares owned currently: 445,779 rights
- Number of rights to be exercised:
+ Number of rights to transfer: 18,000 rights
+ Number of rights registered to purchase: 463,779 rights 
- Expected value (caculated based on par value): VND695,660,000
- Nature of transaction: receiving transfer of buy rights and exercising buy rights
 - Number of shares to be acquired corresponding to the holding of share purchase rights after transaction: 515,345 shares
- Trading method: in pursuit of the Company's regulations in the Announcement on public offering
- Expected Start date of transaction: 18/12/2025
- Expected End date of transaction: 25/12/2025
 ..............................................................................................................................
- Name of issuer: Agimexpharm Pharmaceutical Joint Stock Company
- Stock code: AGP
- Securities type: Common stock
- Name of person discharging managerial responsibility (PDMR)/Director: Nguyen Van Kha
- Position in the listed company: Vice Chair of the Board of-Director-cum-Managing Director 
- Number of shares held by person discharging managerial responsibility (PDMR)/Director: 3,394,846 shares (12.76%)
- Number of rights to purchase shares owned currently: 3,394,846 rights
- Number of rights to be exercised:
+ Number of rights to transfer: 2,467,227 rights
+ Number of rights registered to purchase: 927,619 rights
- Expected value (caculated based on par value): VND5,092,260,000
- Nature of transaction: receiving transfer of buy rights and exercising buy rights
 - Number of shares to be acquired corresponding to the holding of share purchase rights after transaction: 3,533,988 shares
- Trading method: in pursuit of the Company's regulations in the Announcement on public offering
- Expected Start date of transaction: 08/12/2025
- Expected End date of transaction: 25/12/2025
..............................................................................................................................
- Name of issuer: Agimexpharm Pharmaceutical Joint Stock Company
- Stock code: AGP
- Securities type: Common stock
- Name of person discharging managerial responsibility (PDMR)/Director: Huynh Hoang Ha
- Position in the listed company: Director-cum-Deputy Managing Director
- Number of shares held by person discharging managerial responsibility (PDMR)/Director: 210,000 shares (0.79%)
- Number of rights to purchase shares owned currently: 210,000 rights
- Number of rights to be exercised:
+ Number of rights to transfer: 200,000 rights
+ Number of rights registered to purchase: 410,000 rights 
- Expected value (caculated based on par value): VND615,000,000
- Nature of transaction: receiving transfer of buy rights and exercising buy rights
 - Number of shares to be acquired corresponding to the holding of share purchase rights after transaction: 271,500 shares
- Trading method: in pursuit of the Company's regulations in the Announcement on public offering
- Expected Start date of transaction: 08/12/2025
- Expected End date of transaction: 25/12/2025
..............................................................................................................................
- Name of issuer: Agimexpharm Pharmaceutical Joint Stock Company
- Stock code: AGP
- Securities type: Common stock
- Name of person discharging managerial responsibility (PDMR): Tran Thi Thanh Hang
- Position in the listed company: Chief of the Supervisory Board
- Number of shares held by person discharging managerial responsibility (PDMR): 36,042 shares (0.14%)
- Number of rights to purchase shares owned currently: 36,042 rights
- Number of rights registered to purchase: 36,042 rights
- Expected value (caculated based on par value): VND54,600,000
- Nature of transaction: receiving transfer of buy rights and exercising buy rights
 - Number of shares to be acquired corresponding to the holding of share purchase rights after transaction: 41,862 shares
- Trading method: in pursuit of the Company's regulations in the Announcement on public offering
- Expected Start date of transaction: 08/12/2025
- Expected End date of transaction: 25/12/2025
 
..............................................................................................................................
- Name of issuer: Agimexpharm Pharmaceutical Joint Stock Company
- Stock code: AGP
- Securities type: Common stock
- Name of person discharging managerial responsibility (PDMR): Vu Minh Tuan
- Position in the listed company: Deputy Managing Director
- Number of shares held by person discharging managerial responsibility (PDMR): 113,299 shares (0.43%)
- Number of rights to purchase shares owned currently: 113,299 rights
- Number of shares to be exercised:
+ Number of rights to transfer: 13,547 rights
+ Number of rights registered to purchase: 99,752 rights
- Expected value (caculated based on par value): VND169,940,000
- Nature of transaction: receiving transfer of buy rights and exercising buy rights
 - Number of shares to be acquired corresponding to the holding of share purchase rights after transaction: 128,261 shares
- Trading method: in pursuit of the Company's regulations in the Announcement on public offering
- Expected Start date of transaction: 08/12/2025
- Expected End date of transaction: 25/12/2025
..............................................................................................................................
- Name of issuer: Agimexpharm Pharmaceutical Joint Stock Company
- Stock code: AGP
- Securities type: Common stock
- Name of person discharging managerial responsibility (PDMR: Lam Tri Hien
- Position in the listed company: Deputy Managing Director
- Number of shares held by person discharging managerial responsibility (PDMR): 137,962 shares (0.52%)
- Number of rights to purchase shares owned currently: 137,962 rights
- Number of rights to be exercised:
+ Number of rights to transfer: 80,667 rights
+ Number of shares registered to purchase: 218,629 rights 
- Expected value (caculated based on par value): VND327,940,000
- Nature of transaction: receiving transfer of buy rights and exercising buy rights
 - Number of shares to be acquired corresponding to the holding of share purchase rights after transaction: 170,756 shares
- Trading method: in pursuit of the Company's regulations in the Announcement on public offering
- Expected Start date of transaction: 08/12/2025
- Expected End date of transaction: 25/12/2025
..............................................................................................................................
- Name of issuer: Agimexpharm Pharmaceutical Joint Stock Company
- Stock code: AGP
- Securities type: Common stock
- Name of person discharging managerial responsibility (PDMR): Tran Nguyen Minh Hien
- Position in the listed company: Chief Accountant
- Number of shares held by person discharging managerial responsibility (PDMR): 70,078 shares (0.26%)
- Number of rights to purchase shares owned currently: 70,078 rights
- Number of rights to be exercised:
+ Number of rights to transfer: 23,887 rights
+ Number of shares tregistered to purchase: 93,965 rights 
- Expected value (caculated based on par value): VND140,940,000
- Nature of transaction: receiving transfer of buy rights and exercising buy rights
 - Number of shares to be acquired corresponding to the holding of share purchase rights after transaction: 84,172 shares
- Trading method: in pursuit of the Company's regulations in the Announcement on public offering
- Expected Start date of transaction: 08/12/2025
- Expected End date of transaction: 25/12/2025
..............................................................................................................................
- Name of issuer: Agimexpharm Pharmaceutical Joint Stock Company
- Stock code: AGP
- Securities type: Common stock
- Name of connected person: Le Van Mac
- Name of person discharging managerial responsibility (PDMR): Le Minh Ngoc
- Position in the listed company: Authorized Information Disclosure Officer-cum-Company's Secretary
- Relation between connected person and PDMR: Father
- Number of shares held by person discharging managerial responsibility (PDMR)/Director: 6,406 shares (0.02%).
- Number of shares held by connected person before transaction: 133,156 shares (0.5%)
- Number of rights to purchase shares owned currently: 133,156 rights
- Number of rights to be exercised:
+ Number of rights to transfer: 12,000 rights
- Number of rights registered to purchase: 145,156 rights 
- Expected value (caculated based on par value): VND217,730,000
- Nature of transaction: receiving transfer of buy rights and exercising buy rights
 - Number of shares to be acquired corresponding to the holding of share purchase rights after transaction: 154,929 shares
- Trading method: in pursuit of the Company's regulations in the Announcement on public offering
- Expected Start date of transaction: 08/12/2025
- Expected End date of transaction: 25/12/2025
..............................................................................................................................
- Name of issuer: Agimexpharm Pharmaceutical Joint Stock Company
- Stock code: AGP
- Securities type: Common stock
- Name of connected person: Lam Hoang Anh
- Name of person discharging managerial responsibility (PDMR)/Director: Le Minh Ngoc
- Position in the listed company: Authorized Information Disclosure Officer-cum-Company's Secretary
- Relation between connected person and PDMR/Director: Mother
- Number of shares held by person discharging managerial responsibility (PDMR)/Director: 6,406 shares (0.02%).
- Number of shares held by connected person before transaction: 37,100 shares (0.14%)
- Number of rights to purchase shares owned currently: 37,100 rights
- Number of rights to be exercised:
+ Number of rights to transfer: 299,860 rights
+ Number of shares registered to purchase: 336,960 rights 
- Expected value (caculated based on par value): VND505,440,000
- Nature of transaction: receiving transfer of buy rights and exercising buy rights
 - Number of shares to be acquired corresponding to the holding of share purchase rights after transaction: 87,644 shares
- Trading method: in pursuit of the Company's regulations in the Announcement on public offering
- Expected Start date of transaction: 08/12/2025
- Expected End date of transaction: 25/12/2025
..............................................................................................................................
- Name of issuer: Agimexpharm Pharmaceutical Joint Stock Company
- Stock code: AGP
- Securities type: Common stock
- Name of connected person: Nguyen Thai Cuong
- Name of person discharging managerial responsibility (PDMR): Le Minh Ngoc
- Position in the listed company: Authorized Information Disclosure Officer-cum-Company's Secretary
- Relation between connected person and PDMR: Husband
- Number of shares held by person discharging managerial responsibility (PDMR)/Director: 6,406 shares (0.02%).
- Number of shares held by connected person before transaction: 64,380 shares (0.24%)
- Number of rights to purchase shares owned currently: 64,380 rights
- Number of rights registered to purchase: 64,380 rights
- Expected value (caculated based on par value): VND96,570,000
- Nature of transaction: receiving transfer of buy rights and exercising buy rights
 - Number of shares to be acquired corresponding to the holding of share purchase rights after transaction: 64,380 shares
- Trading method: in pursuit of the Company's regulations in the Announcement on public offering
- Expected Start date of transaction: 08/12/2025
- Expected End date of transaction: 25/12/2025